🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Natural Capsules Limited NATCAPSUQ NSEPHARMA

Healthcare · Drug Manufacturers - Specialty & Generic · India
https://www.naturalcapsules.com
Company Profile ↓
₹143.00
-36.11% 1Y
Mkt Cap₹148.52 Cr
P/E-6.00
P/B0.46
52W High₹276.93
52W Low₹142.11
Book Value₹213.40
EPS (TTM)₹-23.84

Company Overview

Natural Capsules Limited engages in the manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy-free gelatin, shiny gelatin, sodium lauryl sulfate-free gelatin, halal-certified gelatin, fast-release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form. Natural Capsules Limited was incorporated in 1993 and is based in Bengaluru, India.

Recent Developments

  • Mar 2026 Revenue of ₹187.20 Cr (+10.6% YoY); net profit ₹-24.66 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +10.6%, earnings -4094.7%.
  • 5-Year Trend Long-term compounding — revenue CAGR 4.4%, profit CAGR -77.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:4.36%
1 Year:10.64%

Compounded Profit Growth

5 Years:-77.90%
1 Year:-4,094.72%

Stock Price Performance

1 Year:-36.11%
6 Months:-23.43%
3 Months:-13.89%
1 Month:-6.75%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 1% of range
₹142.11 ₹276.93
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)37.39 · Neutral
Price Performance
1M-6.75%
3M-13.89%
6M-23.43%
1Y-36.11%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Earnings shrank at -77.9% CAGR over 5 years.
  • Trading 48.4% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-6.00
Industry PE
39.97
Forward P/E
-
PEG Ratio
-
Book Value
₹213.40
Price to Book
0.46
P/S
0.80
EV/EBITDA
-145.18
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
4.36%
Profit 5Y
-77.90%
Revenue (YoY)
10.64%
Earnings (YoY)
-4,094.72%

Profitability & Returns

ROCE
-5.82%
ROE
-11.13%
ROA
-5.81%
Profit Margin
-13.17%
Op Margin
-9.99%
Gross Margin
45.33%
EPS (Latest Qtr)
₹-4.82
EPS (TTM)
₹-23.84

Balance Sheet & Liquidity

Debt/Equity
0.52
Quick Ratio
0.83
Current Ratio
1.03
Debt
₹115.48 Cr
Total Assets
₹424.16 Cr
Current Assets
₹136.80 Cr
Working Capital
₹4.07 Cr

Ownership

Promoter Holding
65.53%
Chg in Prom Hold
14.49%
FII / Inst Holding
0.00%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
₹148.52 Cr
Total Revenue (TTM)
₹187.20 Cr
EBITDA
₹17.20 L
Free Cash Flow
₹-61.33 L
Operating Cash Flow
₹10.92 Cr
Shares Outstanding
₹1.04 Cr
Gross Margin
45.33%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 NATCAPSUQ Natural Capsules Limited NSEPHARMA 143.00 -6.00 ₹148.52 Cr 0.00% -5.82% -11.13% 4.36% -77.90%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,948.80 40.77 ₹4.68 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,315.50 75.61 ₹1.94 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,952.20 87.70 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,981.00 66.51 ₹1.29 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,440.10 22.07 ₹1.16 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,137.40 22.71 ₹1.14 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,494.30 21.42 ₹1.14 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,099.00 99.82 ₹1.07 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 37.62 Cr37.70 Cr37.52 Cr39.98 Cr40.22 Cr39.18 Cr41.22 Cr43.83 Cr44.97 Cr45.20 Cr45.80 Cr37.75 Cr58.45 Cr
Cost of Revenue --------22.81 Cr23.57 Cr24.32 Cr18.97 Cr35.48 Cr
Gross Profit --------22.17 Cr21.63 Cr21.48 Cr18.77 Cr22.97 Cr
Operating Expenses 31.85 Cr31.74 Cr32.40 Cr35.26 Cr36.11 Cr34.81 Cr36.72 Cr39.56 Cr19.94 Cr25.52 Cr26.66 Cr25.46 Cr25.92 Cr
Operating Income 3.90 Cr3.85 Cr2.95 Cr2.53 Cr1.91 Cr2.09 Cr2.15 Cr1.94 Cr2.23 Cr-3.89 Cr-5.17 Cr-6.69 Cr-2.95 Cr
EBITDA 5.77 Cr5.96 Cr5.12 Cr4.72 Cr4.11 Cr4.37 Cr4.50 Cr4.27 Cr4.69 Cr67.77 L-72.31 L-1.88 Cr2.09 Cr
Interest Expense 1.12 Cr1.33 Cr1.16 Cr1.24 Cr1.40 Cr1.49 Cr1.65 Cr1.54 Cr1.64 Cr2.53 Cr2.68 Cr2.85 Cr2.89 Cr
Pretax Income 2.99 Cr2.69 Cr2.14 Cr1.79 Cr1.43 Cr78.00 L61.00 L51.00 L89.13 L-6.06 Cr-7.70 Cr-9.08 Cr-5.08 Cr
Tax Provision 1.20 Cr86.99 L57.99 L59.00 L46.00 L17.00 L1.23 Cr40.00 L37.05 L-48.39 L-70.59 L-1.97 Cr-9.97 L
Net Income 1.79 Cr1.82 Cr1.56 Cr1.21 Cr97.00 L60.00 L-61.00 L11.00 L52.07 L-5.58 Cr-6.99 Cr-7.12 Cr-4.98 Cr
Diluted EPS 1.941.961.681.301.040.64-0.600.110.13-5.40-6.76-6.88-4.82

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 55.00 Cr60.00 Cr62.00 Cr80.00 Cr-164.72 Cr151.29 Cr169.21 Cr187.20 Cr
Cost of Revenue -----81.91 Cr82.36 Cr84.91 Cr102.35 Cr
Gross Profit -----82.81 Cr68.93 Cr84.30 Cr84.86 Cr
Operating Expenses 49.00 Cr55.00 Cr56.00 Cr68.00 Cr-55.57 Cr58.61 Cr75.90 Cr103.56 Cr
Operating Income 2.00 Cr2.00 Cr1.00 Cr7.00 Cr-27.24 Cr10.32 Cr8.40 Cr-18.70 Cr
EBITDA 6.00 Cr5.00 Cr5.00 Cr11.00 Cr-35.61 Cr21.85 Cr18.22 Cr17.20 L
Interest Expense 01.00 Cr1.00 Cr1.00 Cr-3.41 Cr5.13 Cr6.31 Cr10.95 Cr
Pretax Income 2.00 Cr2.00 Cr1.00 Cr9.00 Cr-24.99 Cr8.05 Cr2.79 Cr-27.92 Cr
Tax Provision 68.00 L14.00 L38.00 L2.16 Cr-6.55 Cr2.50 Cr2.17 Cr-3.26 Cr
Net Income 1.00 Cr2.00 Cr1.00 Cr7.00 Cr-18.45 Cr5.55 Cr61.74 L-24.66 Cr
Diluted EPS 1.192.060.927.43-19.865.970.22-23.84

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 73.00 Cr75.00 Cr76.00 Cr99.00 Cr-288.76 Cr376.53 Cr419.35 Cr424.16 Cr
Current Assets -----101.51 Cr123.77 Cr129.59 Cr136.80 Cr
Cash & Equivalents -----1.27 Cr1.95 Cr66.29 L22.03 L
Inventory -----8.85 Cr19.04 Cr25.46 Cr26.33 Cr
Receivables -----52.13 Cr54.47 Cr62.24 Cr71.35 Cr
Total Liabilities -----140.51 Cr147.72 Cr162.19 Cr189.44 Cr
Current Liabilities -----66.94 Cr76.49 Cr99.99 Cr132.73 Cr
Long Term Debt -----70.39 Cr67.93 Cr56.40 Cr54.72 Cr
Total Debt 05.00 Cr6.00 Cr10.00 Cr-96.79 Cr109.01 Cr105.19 Cr115.48 Cr
Total Equity 54.00 Cr55.00 Cr55.00 Cr62.00 Cr-123.23 Cr203.80 Cr232.94 Cr221.64 Cr
Shares Outstanding -----92.76 L93.49 L1.04 Cr1.04 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 5.00 Cr2.00 Cr7.00 Cr6.00 Cr-17.22 Cr-8.35 Cr26.75 Cr10.92 Cr
Investing Cash Flow -1.00 Cr-7.00 Cr-6.00 Cr-9.00 Cr--104.63 Cr-72.59 Cr-44.48 Cr-10.77 Cr
Financing Cash Flow -4.00 Cr4.00 Cr-1.00 Cr3.00 Cr-87.49 Cr81.72 Cr16.17 Cr-62.02 L
Capital Expenditure -1.00 Cr-7.00 Cr-5.00 Cr-17.00 Cr--105.89 Cr-71.63 Cr-44.63 Cr-11.53 Cr
Free Cash Flow 4.00 Cr-5.00 Cr2.00 Cr-11.00 Cr--88.67 Cr-79.98 Cr-17.88 Cr-61.33 L
Net Change in Cash 0-1.00 Cr0-0-7.92 L77.70 L-1.57 Cr-46.85 L

Ratios (Annual)

Figures in %.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -----50.3%45.6%49.8%45.3%
Operating Margin % 3.6%3.3%1.6%8.8%-16.5%6.8%5.0%-10.0%
Net Margin % 1.8%3.3%1.6%8.8%-11.2%3.7%0.4%-13.2%
ROE % 1.9%3.6%1.8%11.3%-15.0%2.7%0.3%-11.1%
ROCE % -----12.3%3.4%2.6%-6.4%

Shareholding Pattern

Insiders
65.53%
Institutions
0.00%
Public Float
0.00%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NATCAPSUQ

Google News Sun, 21 Sep 2025

Natural Capsules Limited (NSE:NATCAPSUQ) Stock Catapults 26% Though Its Price And Business Still Lag The Industry - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxNZEZTa1cxOTQwczdGejVTdEJ3U0dyUy12SWZTWldmenljZ19RZnBNODVUb0d5ZXdFdjNyLUdZaERzRWFhdEI0WU0wLW1iZ3ZMYllkOWtRMjJIQ1JPVFlZVE1EWmYweGFqZGUzN1p5U0tOZFRuRjJuYmFPZ1BGOGdtX0dxT1RsdFlRMzhMbC…

Google News hu, 20 Mar 2025

Natural Capsules Ltd. Share Price Today - Natural Capsules Ltd. Stock Price Live NSE/BSE - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE5faTV2b3pkd1l6YmlGMHA0dDRWVkRsdDRGaVFHWkNnYnhWeHlrVFNMMUlWSG9yT09HSXR5UDBUekFIbUx3ZzlwNnBiU2dfZ2R6NDRkSE9LX3JRZTdOYlJJeW1yQ0RLc2xDek1FaHVuNUpIVjNFRnNOVnY5ajQwUQ?oc=5" target="_blan…

Google News hu, 03 Aug 2017

AMRUTANJAN Stock Price and Chart — NSE:AMRUTANJAN - TradingView

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1uMjdpWVIwS0VhQ0k4d3UtVEpnVmJTYjlLS08tU3lwS0tPV2g3WUJNbHprVU5MTDhiUWlydC00WEptWXFKaWU5eDVXTnlqdlpOZHRnSnZlMVFoaW9uRDBtQw?oc=5" target="_blank">AMRUTANJAN Stock Price and Chart — NS…

Google News ue, 05 Aug 2025

Natural Capsules Limited Releases Q2 2025 Financial Results - TipRanks

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOWmowanJyWXZLZWp0am1SNzY0TDJiR01VcV9EeG84enE4UGtia2lFQURzbXBmdWdzcTNDSTBfS3NhTGw4QkRLNjBZcTZ1ZG1MRWtJVjJKT21qVzhmQTRmVkNmcTNoZ2wzcEdDX2tzVjdYTi1LbmpCQ0xfRjc4eGF5T3JSUHBuX1lkMGxXdT…

NATCAPSUQ — Frequently Asked Questions

What is the current share price of Natural Capsules Limited (NATCAPSUQ)?

As of 2026-07-15 09:52 IST, Natural Capsules Limited (NATCAPSUQ) trades at ₹143.00 on NSE. Its 52-week range is ₹142.11 to ₹276.93.

What is the market capitalisation of NATCAPSUQ?

Natural Capsules Limited (NATCAPSUQ) has a market capitalisation of ₹148.52 Cr on NSE.

What is the P/E ratio of NATCAPSUQ?

NATCAPSUQ trades at a trailing price-to-earnings (P/E) ratio of -6.00. The industry average P/E is 39.97. Its price-to-book (P/B) ratio is 0.46.

What is the return on equity (ROE) of NATCAPSUQ?

NATCAPSUQ has a return on equity (ROE) of -11.13%. Its return on capital employed (ROCE) is -5.82%.

Is NATCAPSUQ a good stock to buy?

This page provides a data-driven analysis of Natural Capsules Limited (NATCAPSUQ), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space